HomeMedRhythms

MedRhythms

MedRhythms Reports: Breakthrough Device Designation for Chronic Stroke Digital Therapeutic Receives FDA Approval

"There is currently no standard of care for chronic stroke survivors with walking deficits, yet these impairments are strongly linked to fall risk, lack of independence, and decreased quality of life.

MedRhythms Advances Pipeline of Neurologic Rehabilitation Products in Multiple Sclerosis, Parkinson’s Disease

MedRhythms, a prescription digital therapeutics company, assembles Scientific Advisory Boards for multiple sclerosis and Parkinson's disease with world-leading researchers, and a study of the Company's multiple sclerosis pipeline product (MR-004) to be launched.